Development of concentrated and rapidly absorbed insulins for closed loop systems

Ended Project Grant Awarded Last action

Award ID
R43DK096604
Recipient
Awarding agency
Obligated
$582,473

Award facts

Assistance listing
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
Completion date
Place of performance
Danbury, CT 06810, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $141,237
Amendment $150,000
Amendment $141,236
Original award $150,000

Quick answers

Who received award R43DK096604?

R43DK096604 was awarded to Albireo Pharma, Inc. by National Institutes of Health (Department of Health and Human Services) on August 1, 2012.

How much is award R43DK096604 worth?

$582,473 has been obligated on R43DK096604.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award